Citation Impact

Citing Papers

Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis
2007
CD73 Is Associated with Poor Prognosis in High-Grade Serous Ovarian Cancer
2015
Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs
2013
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
2015
Counting Cytokinesis Proteins Globally and Locally in Fission Yeast
2005 Science
Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
2014
Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial–Mesenchymal Transition Predicts for Human Breast Cancer Recurrence
2011
CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis
2011
Counting Low-Copy Number Proteins in a Single Cell
2007 StandoutScienceNobel
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
2012
Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
2011
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Comparative proteomic and transcriptomic profiling of the fission yeast Schizosaccharomyces pombe
2007
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment
2017
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia
2003 Standout
Cellular function and molecular structure of ecto-nucleotidases
2012
Targeting immunosuppressive adenosine in cancer
2017
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Extracellular adenosine triphosphate and adenosine in cancer
2010
YAP/TAZ at the Roots of Cancer
2016
TGF-β signalling-related markers in cancer patients with bone metastasis
2008
Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor
2011
Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers
2015
Cancer drug resistance: an evolving paradigm
2013 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection
2014
The biology and function of fibroblasts in cancer
2016 Standout
Graft-versus-Host Disease Is Enhanced by Selective CD73 Blockade in Mice
2013
Roles of TGFβ in metastasis
2008
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer
2013 StandoutNobel
TGFβ signalling: a complex web in cancer progression
2010
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity
2011
Cyclebase.org a comprehensive multi-organism online database of cell-cycle experiments
2007
The Perseus computational platform for comprehensive analysis of (prote)omics data
2016 Standout
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
2013
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment
2009
Hypoxia-HIF-1α-C/EBPα/Runx1 signaling in leukemic cell differentiation
2009
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Emerging Biological Principles of Metastasis
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets
2015 Standout
Targeting metastasis
2016
Immune microenvironments in solid tumors: new targets for therapy
2011
TGFβ in Cancer
2008 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
miR-194 Is a Marker of Hepatic Epithelial Cells and Suppresses Metastasis of Liver Cancer Cells in Mice
2010
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Combination cancer immunotherapies tailored to the tumour microenvironment
2015
Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling
2014
Future directions of bone-targeted therapy for metastatic breast cancer
2010
Sheep, wolf, or werewolf: Cancer stem cells and the epithelial-to-mesenchymal transition
2013
Adenosine receptors as drug targets — what are the challenges?
2013
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
2010
Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor
2015
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
2016
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Peripheral TGF-β1 Signaling Is a Critical Event in Bone Cancer-Induced Hyperalgesia in Rodents
2013
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
2013
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors
2018 StandoutNobel
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma
2012
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Correlation of the cytotoxic effects of cationic lipids with their headgroups
2018
Immunological mechanisms of the antitumor effects of supplemental oxygenation
2015
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
High-Throughput Synthesis of Single-Layer MoS2 Nanosheets as a Near-Infrared Photothermal-Triggered Drug Delivery for Effective Cancer Therapy
2014
Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion.
2014
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Blockade of A 2A receptors potently suppresses the metastasis of CD73 + tumors
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
2017
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
2011
Identification of a pharmacologically tractable Fra-1/ADORA2B axis promoting breast cancer metastasis
2013
Anti‐CD73 therapy impairs tumor angiogenesis
2013
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
2013 StandoutScience
A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
2016
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Chromatin-Bound p53 Anchors Activated Smads and the mSin3A Corepressor To Confer Transforming Growth Factor β-Mediated Transcription Repression
2008
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
2014
Molecular Biology of Bone Metastasis
2007
Genome-wide transcriptional analysis of the human cell cycle identifies genes differentially regulated in normal and cancer cells
2008
Intelligent MoS2 Nanotheranostic for Targeted and Enzyme-/pH-/NIR-Responsive Drug Delivery To Overcome Cancer Chemotherapy Resistance Guided by PET Imaging
2018
Chemical Glycoproteomics
2016 StandoutNobel
Integrin–TGF‐β crosstalk in fibrosis, cancer and wound healing
2010

Works of Long Wang being referenced

CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
2010
An essential role for DNA methyltransferase 3a in melanoma tumorigenesis
2009
TAZ promotes epithelial to mesenchymal transition via the upregulation of connective tissue growth factor expression in neuroblastoma cells
2014
Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models
2010
Inhibition of Skeletal Metastasis by Ectopic ERα Expression in ERα-Negative Human Breast Cancer Cell Lines
2007
Systemic administration of a soluble betaglycan suppresses tumor growth, angiogenesis, and matrix metalloproteinase-9 expression in a human xenograft model of prostate cancer
2004
Identification of Cell Cycle-regulated Genes in Fission Yeast
2004
Screening Antitumor Bioactive Fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and Sensitive Cell Lines with the Serum Pharmacology Method and Identification by UPLC-TOF-MS
2015
Dual Role of SnoN in Mammalian Tumorigenesis
2006
Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo
2001
Inhibition of Pulmonary and Skeletal Metastasis by a Transforming Growth Factor-β Type I Receptor Kinase Inhibitor
2006
Rankless by CCL
2026